Back to search
Lung Cancer Non-Small Cell Stage IIIB/IIIC/IV
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Lung Cancer Non-Small Cell Stage IIIB/IIIC/IV trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Lung Cancer Non-Small Cell Stage IIIB/IIIC/IV trials you may qualify forThis study will evaluate two study drugs called ubamatamab and REGN7075, to see if they can help treat advanced or metastatic Non-Small Cell Lung Cancer (NSCLC)…
This phase III trial compares the effect of adding chemotherapy to immunotherapy (pembrolizumab) versus immunotherapy alone in treating patients with stage IIIB…
This trial studies how well dyadic yoga intervention works in improving physical performance and quality of life in patients with stage I-IV non-small cell lung…
This phase I/II trial tests the safety and tolerability of an experimental personalized vaccine when given by itself and with pembrolizumab in treating patients…
This trial studies the role of the gut microbiome and effectiveness of a fecal transplant on medication-induced gastrointestinal (GI) complications in patients…
This phase II trial studies the effect of adaptive radiation planning in reducing side effects associated with radiation treatment and immunotherapy in patients…
This study compares the outcomes and safety of two standard treatment options called microwave ablation and surgical wedge resection in patients with non-small…
This phase III trial studies whether pembrolizumab alone as a first-line treatment, followed by pemetrexed and carboplatin with or without pembrolizumab after d…